Objectives: To determine the behavior of lupus nephropathy (LN) in a population group of a reference center in the Colombian Caribbean during 2012 and 2013, analyzing the most prevalent clinical and laboratory findings and its relation to the immunohistotopathological findings, define the class of Lupus nephritis with greater prevalence and the clinical or paraclinic data more correlated with this one. Methods: Descriptive, retrospective, cross-sectional study conducted from January 1st of 2012 to December 31st 2013, which included 53 patients with systemic lupus erythematosus according to diagnostic critearia of the Colegio Americano de Reumatologia, with manifestations of renal impairment. Results: In our study population in th...
Purpose: The pathological manifestations in the kidneys in systemic lupus erythematosus (SLE) are co...
Background: Systemic lupus erythematosus (SLE) is a chronic, auto immune disorder and multisystem. T...
Introduction:Lupus Nephritis (LN) affects 25-60% of people with Systemic Lupus Erythematosus (SLE) w...
Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) ...
Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) ...
The aim of the study was to profile those patients included in the RELESSER registry with histologic...
Lupus nephritis (LN) occurs between 30% and 70% of patients with systemic lupus erythematosus (SLE),...
The aim of the study was to profile those patients included in the RELESSER registry with histologic...
INTRODUCTION: Systemic lupus erythematosus is a chronic inflammatory disease with multisystem invol...
Context: Lupus nephritis (LN) is the involvement of kidney in systemic lupus erythematosus (SLE) whe...
Purpose: Lupus nephritis is one of the most serious manifestations of Systemic lupus erythematosis a...
Objective: Lupus nephritis (LN) is the most common and serious manifestation of systemic lupus eryth...
Work was made at: Hospital of Lithuanian University of Health Sciences Kauno klinikos. Purpose: To e...
INTRODUÇÃO: O Brasil tem uma população caracteristicamente miscigenada e é o país americano com o ma...
Objective. To determine nephritis outcomes in a prospective multi-ethnic/racial SLE inception cohort...
Purpose: The pathological manifestations in the kidneys in systemic lupus erythematosus (SLE) are co...
Background: Systemic lupus erythematosus (SLE) is a chronic, auto immune disorder and multisystem. T...
Introduction:Lupus Nephritis (LN) affects 25-60% of people with Systemic Lupus Erythematosus (SLE) w...
Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) ...
Lupus nephritis (LN) is one of the most serious complications of systemic lupus erythematosus (SLE) ...
The aim of the study was to profile those patients included in the RELESSER registry with histologic...
Lupus nephritis (LN) occurs between 30% and 70% of patients with systemic lupus erythematosus (SLE),...
The aim of the study was to profile those patients included in the RELESSER registry with histologic...
INTRODUCTION: Systemic lupus erythematosus is a chronic inflammatory disease with multisystem invol...
Context: Lupus nephritis (LN) is the involvement of kidney in systemic lupus erythematosus (SLE) whe...
Purpose: Lupus nephritis is one of the most serious manifestations of Systemic lupus erythematosis a...
Objective: Lupus nephritis (LN) is the most common and serious manifestation of systemic lupus eryth...
Work was made at: Hospital of Lithuanian University of Health Sciences Kauno klinikos. Purpose: To e...
INTRODUÇÃO: O Brasil tem uma população caracteristicamente miscigenada e é o país americano com o ma...
Objective. To determine nephritis outcomes in a prospective multi-ethnic/racial SLE inception cohort...
Purpose: The pathological manifestations in the kidneys in systemic lupus erythematosus (SLE) are co...
Background: Systemic lupus erythematosus (SLE) is a chronic, auto immune disorder and multisystem. T...
Introduction:Lupus Nephritis (LN) affects 25-60% of people with Systemic Lupus Erythematosus (SLE) w...